14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
HAE vs UFPT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
HAE Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 6–4 Matrix Metrics)
HAE Overall Winner
6-Pillar Tally: HAE 4 – 1 UFPT (1 Tie)
Matrix Metrics: HAE 6 – 4 UFPT
As of Nov 16, 2026, Haemonetics Corporation (HAE) is the stronger overall head-to-head candidate over UFP Technologies Inc (UFPT) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). HAE carries a Unified Composite Score of 51.4/100 (HOLD) at $121.34 (22.9x Forward P/E, 18.8% operating margin), whereas UFPT carries 42.6/100 (HOLD) at $298.54 (24.7x Forward P/E, 15.4% operating margin).
Technical & Structure Timing Caution: HAE trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 59.0); meanwhile UFPT is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HAE vs UFPT. Trailing 12-month operating profitability (HAE 18.8% vs UFPT 15.4%) and valuation multiples (HAE 22.9x vs UFPT 24.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Devices value chain with $2.4B market capitalization and 15.4% operating margin.
OpEx & R&D Reinvestment13.5% of Rev ($88M)
90D Engineering Disclosures0 Published
Investor FAQ HAE vs UFPT Key Questions & Quantitative Answers
As of Nov 16, 2026, Haemonetics Corporation (HAE) is the stronger overall head-to-head candidate over UFP Technologies Inc (UFPT) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). HAE carries a Unified Composite Score of 51.4/100 (HOLD) at $121.34 (22.9x Forward P/E, 18.8% operating margin), whereas UFPT carries 42.6/100 (HOLD) at $298.54 (24.7x Forward P/E, 15.4% operating margin). Technical & Structure Timing Caution: HAE trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 59.0); meanwhile UFPT is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
UFPT leads the Growth & Scale pillar: HAE posts +9.3% YoY revenue growth and +23.5% YoY earnings growth on $1.38B TTM revenue (59.8% gross margin, 18.8% operating margin), compared with UFPT at +11.6% YoY revenue growth and +25.1% YoY earnings growth on $650M TTM revenue (28.9% gross margin, 15.4% operating margin). On trailing 12-month operating scale, HAE generates $1.38B in USD-normalized revenue versus $650M for UFPT. In operating R&D and SG&A reinvestment, HAE deploys 41.0% of Rev ($567M) (0 90-day corporate R&D disclosures) versus 13.5% of Rev ($88M) (0 disclosures) for UFPT.
HAE screens cheaper on headline valuation multiples. HAE trades at 22.9x Forward P/E, 54.4x Trailing P/E, 1.92x PEG, and 4.0x EV/Revenue (26.3% EBITDA margin), whereas UFPT trades at 24.7x Forward P/E, 31.2x Trailing P/E, 3.80x PEG, and 3.6x EV/Revenue (18.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HAE (11.9% ROE) versus UFPT (17.2% ROE) capital efficiency.
In options market volatility and institutional positioning, HAE carries 32.7% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.27β · 32% Vol realized risk). By comparison, UFPT carries 42.3% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.64β · 77% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.